• Research & Development

  INOpulse therapy for PH associated with COPD to enter phase 2b trial in US

  Posted by Pulmonary Hypertension News Moderator on May 18, 2018 at 5:24 pm

  Bellerophon Therapeutics announced that it is moving forward with a planned Phase 2b trial that will investigate INOpulse as a therapy for pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), following an agreement with the U.S. Food and Drug Administration regarding the study’s design.

  Read the fully story here: INOpulse Therapy for PH Associated with COPD to Enter Phase 2b Trial in US

  Are you familiar with INOpulse therapy? What are your thoughts on this news?

  replied 7 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply